Celldex Therapeutics
Developing antibodies that address devastating diseases for which available treatments are inadequate. Learn more
Launch date
Employees
Market cap
$2.8b
Enterprise valuation
$2.0b (Public information from Sep 2024)
Share price
$41.16 CLDX
Hampton Township Pennsylvania (HQ)
Authorizing premium user...